Literature DB >> 12505803

The neural substrates of affective processing in depressed patients treated with venlafaxine.

Richard J Davidson1, William Irwin, Michael J Anderle, Ned H Kalin.   

Abstract

OBJECTIVE: The purpose of this study was to use functional magnetic resonance imaging (fMRI) to probe the neural circuitry associated with reactivity to negative and positive affective stimuli in patients with major depressive disorder before treatment and after 2 and 8 weeks of treatment with venlafaxine. Relations between baseline neural activation and response to treatment were also evaluated.
METHOD: Patients with major depressive disorder (N=12) and healthy comparison subjects (N=5) were scanned on three occasions, during which trials of alternating blocks of affective and neutral pictorial visual stimuli were presented. Symptoms were evaluated at each testing occasion, and both groups completed self-report measures of mood. Statistical parametric mapping was used to examine the fMRI data with a focus on the group-by-time interactions.
RESULTS: Patients showed a significant reduction in depressive symptoms with treatment. Group-by-time interactions in response to the negative versus neutral stimuli were found in the left insular cortex and the left anterior cingulate. At baseline, both groups showed bilateral activation in the visual cortices, lateral prefrontal cortex, and amygdala in response to the negative versus neutral stimuli, with patients showing greater activation in the visual cortex and less activation in the left lateral prefrontal cortex. Patients with greater relative anterior cingulate activation at baseline in response to the negative versus neutral stimuli showed the most robust treatment response.
CONCLUSIONS: The findings underscore the importance of the neural circuitry activated by negative affect in depression and indicate that components of this circuitry can be changed within 2 weeks of treatment with antidepressant medication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505803     DOI: 10.1176/appi.ajp.160.1.64

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  135 in total

1.  Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.

Authors:  Andrew J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

2.  Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; M Verhoye; J Van Audekerke; G Vanhoutte; Andrew S Lowe; Andrew M Blamire; Thomas Steckler; A Van der Linden; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2010-11-20       Impact factor: 4.530

Review 3.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 4.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

5.  Individual differences in emotion word processing: A diffusion model analysis.

Authors:  Christina J Mueller; Lars Kuchinke
Journal:  Cogn Affect Behav Neurosci       Date:  2016-06       Impact factor: 3.282

6.  The default mode network and self-referential processes in depression.

Authors:  Yvette I Sheline; Deanna M Barch; Joseph L Price; Melissa M Rundle; S Neil Vaishnavi; Abraham Z Snyder; Mark A Mintun; Suzhi Wang; Rebecca S Coalson; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

7.  A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder.

Authors:  Yiheng Tu; Jiliang Fang; Jin Cao; Zengjian Wang; Joel Park; Kristen Jorgenson; Courtney Lang; Jun Liu; Guolei Zhang; Yanping Zhao; Bing Zhu; Peijing Rong; Jian Kong
Journal:  Brain Stimul       Date:  2018-01-31       Impact factor: 8.955

Review 8.  Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology.

Authors:  Robert W Levenson; Virginia E Sturm; Claudia M Haase
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

9.  COGNITION-CHILDHOOD MALTREATMENT INTERACTIONS IN THE PREDICTION OF ANTIDEPRESSANT OUTCOMES IN MAJOR DEPRESSIVE DISORDER PATIENTS: RESULTS FROM THE iSPOT-D TRIAL.

Authors:  Shefali Miller; Lisa M McTeague; Anett Gyurak; Brian Patenaude; Leanne M Williams; Stuart M Grieve; Mayuresh S Korgaonkar; Amit Etkin
Journal:  Depress Anxiety       Date:  2015-04-27       Impact factor: 6.505

10.  Prefrontal mechanisms for executive control over emotional distraction are altered in major depression.

Authors:  Lihong Wang; Kevin S LaBar; Moria Smoski; M Zachary Rosenthal; Florin Dolcos; Thomas R Lynch; Ranga R Krishnan; Gregory McCarthy
Journal:  Psychiatry Res       Date:  2008-05-01       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.